Navigation Links
Revolutionary nanotechnology illuminates brain cells at work

Until now it has been impossible to accurately measure the levels of important chemicals in living brain cells in real time and at the level of a single cell. Scientists at the Carnegie Institution's Department of Plant Biology and Stanford University are the first to overcome this obstacle by successfully applying genetic nanotechnology using molecular sensors to view changes in brain chemical levels. The sensors alter their 3-dimensional form upon binding with the chemical, which is then visible via a process known as fluorescence resonance energy transfer, or FRET. In a new study, the nanosensors were introduced into nerve cells to measure the release of the neurotransmitter glutamate--the major brain chemical that increases nerve-cell activity in mammalian brains. It is involved in everything from learning and memory to mood and perception. Too much glutamate is believed to contribute to conditions such as Alzheimer's and Parkinson's disease. The research is published in the May 30-June 3 on-line early edition of the Proceedings of the National Academy of Sciences.

"The fluorescent imaging technique allows us to see living cells do their jobs live and in color," explained Sakiko Okumoto, lead author of the study at Carnegie. "Understanding when and how glutamate is produced, secreted, reabsorbed, and metabolized in individual brain cells, in real time, will help researchers better understand disease processes and construct new drugs."

"FRET is like two musical tuning forks, which have the same tone," Okumoto continued. "If you excite one, it gives a characteristic tone. If you bring the second fork close to the first one, it will also start to give you a tone even though they do not touch. This is resonance energy transfer."

FRET is used to track the form of proteins that specifically bind metabolites such as sugars and amino acids. A protein of interest is genetically fused with two differently colored tags made from variants of the jelly fish Green Fluorescent Protein (GFP). The colored tags are placed at each end of the molecule making a "biosensor." When the substance of interest binds to the sensor, the sensor backbone becomes reoriented, and the reorientation can be detected. Since light is a vibration, the same response occurs with two fluorescent dyes that have overlapping, but slightly different colors–in this case cyan and yellow versions of GFP. The cyan is excited and, if the distance between the colored proteins changes, more or less energy is transferred to the yellow protein. In this study, the cyan and yellow proteins behave as if they move away from one another when the sensor recognizes glutamate. Thus, there is more cyan and less yellow light than in the absence of glutamate. The sensors are encoded by genes and genetic ZIP codes can be used to target the sensors to any location in the cell and to its surface.

"We used a protein called ybeJ from the common bacterium E. coli. We first predicted the structure of this protein, and then placed the two fluorophores at specific positions on the binding protein," commented co-author Loren Looger. "After fusion to the fluorescent proteins, we placed the sensor on the surface of rat hippocampal cells. The hippocampus is the part of the brain that is involved with emotional reactions, and it helps store learned information in memory. When neurons are activated, they secrete glutamate, and we could see this activity under the microscope by watching the color change. We stimulated the neurons and watched them secrete glutamate in response. We also saw the removal of the glutamate as the neurons returned to normal ready to fire again."

"This is a tremendously exciting technology," remarked Wolf Frommer, leader of the FRET team at Carnegie. "I'm anxious to see what we can learn about the vast complexities of the brain over the coming years, such as the role of glial cells in the process of glutamate removal from the synaptic cleft . It's fascinating to see a tool that we are using in plant biology open new areas in neuroscience."


'"/>

Source:Carnegie Institution


Related biology news :

1. Silver bullet: UGA researchers use laser, nanotechnology to rapidly detect viruses
2. New nanotechnology able to examine single molecules, aiding in determining gene expression
3. Iowa State scientists demonstrate first use of nanotechnology to enter plant cells
4. Drawing with DNA: Bioart illuminates genomics
5. New fruit fly protein illuminates circadian response to light
6. Study illuminates how the plague bacteria causes disease
7. Genome archaeology illuminates the genetic engineering debate
8. Controversial drug shown to act on brain protein to cut alcohol use
9. Mouse brain cells rapidly recover after Alzheimers plaques are cleared
10. Mouse brain tumors mimic those in human genetic disorder
11. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/8/2017)... Inc. (NASDAQ: AWRE ), a leading supplier of ... quarter and year ended December 31, 2016. ... compared to $6.9 million in the same quarter last year. ... million compared to $2.6 million in the fourth quarter of ... $0.5 million, or $0.02 per diluted share, which compares to ...
(Date:2/7/2017)... --  MedNet Solutions , an innovative SaaS-based eClinical technology ... is pleased to announce that the latest release of ... and award winning eClinical solution, is now available for ... a proven Software-as-a-Service (SaaS) clinical research technology platform that ... delivers an entire suite of eClinical tools to support ...
(Date:2/3/2017)... Biomedical Research Institute announced that its Board of Trustees has ... Institute,s new President and CEO. Dr. Schlesinger will take the ... currently the Chair of the Department of Microbial Infection and ... at Ohio State University. "We are delighted to ... Texas Biomed," said Dr. James O. Rubin , Board ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... ... February 24, 2017 , ... Delpor, Inc. (Delpor), a biotechnology company focused on ... of Mental Health (NIMH) for the further advancement of the company’s 3-month olanzapine product ... is expected to deliver therapeutic levels of olanzapine for a period of 3 months., ...
(Date:2/24/2017)... 2017 Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT, ... clinical-stage oncology and dermatology biopharmaceutical company, today is ... in its previously announced rights offering of up ... common stock and Series C Convertible Preferred Stock ... As previously announced, the rights ...
(Date:2/24/2017)... , Feb. 24, 2017 Symic Bio, a ... a new category of therapeutics, announced today the completion ... in peripheral artery disease. The trial will evaluate the ... therapeutic, in the reduction of restenosis following angioplasty. ... development milestone for SB-030," said Nathan Bachtell , ...
(Date:2/24/2017)... -- China Cord Blood Corporation (NYSE: CO ... cord blood collection, laboratory testing, hematopoietic stem cell processing ... financial results for the third quarter and first nine ... Third Quarter of Fiscal 2017 Highlights ... 2017 increased by 18.6% to RMB200.9 million ($28.9 million). ...
Breaking Biology Technology: